Not-for-profit TestRAMP, which launched in 2020 as a marketplace for Covid-19 PCR testing, has now donated over £2 million to good causes, and is also about to launch a new service for genomic testing and profiling of other diseases.
During the pandemic, TestRAMP operated as a not-for-profit earning around £2.4 million in fees. Almost all of this, minus taxes and charges, goes to good causes, with over £2 million donated so far to charities including Alzheimer’s Society, ZSL, and Pilgrim’s Hospices.
TestRAMP has also established TestAID, a charitable foundation that operates as a restricted fund and which it hopes will be able to collaborate with other donors in the diagnostics sector in the future to support good causes in the life sciences.
Mike Hudson, CEO, said:
“We say that we are 100% commercial and 100% philanthropic. That means we charge clients fees, but we operate as a not-for-profit and donate most of our revenue to charity. Our raison d’etre is to make diagnostic testing work better and to support charities at the same time.
“We’re now creating a marketplace so that healthcare providers can see which labs offer particular genomic tests, how much they cost and how quickly they are deliverable. We’ll also be helping labs to co-operate with each other, including to manage supply and demand.”
from UK Fundraising https://ift.tt/R9FbvwQ
0 comments:
Post a Comment